Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | CCR9 | P51686 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.31 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.31 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30332035 | 0.80 | DPP4 (0.46) | DPP4CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL30382604 | 0.77 | CYP1A2 (0.53) | DPP4CCR9CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL25022433 | 0.77 | CYP1A2 (0.53) | DPP4CCR9CYP1A2CYP3A4CYP2C8 | |
| SCHEMBL30332361 | 0.73 | TRPV1 (0.39) | DRD1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL439097 | 0.73 | DPP4 (0.63) | DPP4CCR9 | |
| SCHEMBL30332252 | 0.71 | DPP4 (0.41) | DPP4CCR9 | |
| SCHEMBL30332242 | 0.71 | DPP4 (0.46) | DPP4CCR9CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5616194 | 0.65 | DPP4 (0.59) | DPP4 | |
| SCHEMBL13045975 | 0.65 | DRD1 (0.46) | DRD1CYP1A2CYP3A4 | |
| SCHEMBL28965588 | 0.65 | DPP4 (0.42) | DPP4CCR9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023046128-A1 | A CYCLIN-DEPENDENT KINASE INHIBITOR | Taizhou Eoc Pharma Co., Ltd. (CN) | 2023-03-30 | — | — | WO | disclosed |